(EMAILWIRE.COM, December 22, 2018 ) The mass spectrometry market has been segmented, on the basis of platform, into single mass spectrometry, hybrid mass spectrometry, and other technologies. The hybrid mass spectrometry segment accounted for the largest share of the global mass spectrometry market. The hybrid mass spectrometry segment is further categorized into triple quadrupole, quadrupole time-of-flight (QTOF), and Fourier transform mass spectrometry (FTMS). The high adoption of this spectrometry technique is due to the large volumes of complex data that it yields at high speed and resolutions coupled with technologically advanced products which are available in the market.

Mass spectrometry is an analytical technique used to measure known materials, to identify unknown compounds within a sample, and to evaluate the structure and chemical properties of different molecules. The technique ionizes chemical species and sorts the ions, based on their mass-to-charge ratio. Because of the high sensitivity of these techniques, mass spectroscopy has become a powerful analytical tool for testing in various industries.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=437

The mass spectrometry market in North America is expected to grow at the highest CAGR during the forecast period. North America is the fastest-growing market for mass spectrometry. The key factors influencing the growth of this market include the growing funding for environmental testing in the US, widespread usage of mass spectrometry in the pharmaceutical sector, growing food safety concerns in the US, and government initiatives to improve lab infrastructure and propel fundamental scientific research in Canada.

Mass spectrometry has major applications in the pharmaceutical industry, right from the early stages of drug discovery to the late-stage development and clinical trials. Also, mass spectrometry is routinely employed by pharmaceutical companies as a part of Good Manufacturing Practices (GMPs).

Several pharmacopeias have laid down quality specifications for active pharmaceutical ingredients (APIs) and finished pharmaceutical products (FPPs), which confine the amounts of metal residues and endotoxins in pharmaceutical products to certain limits. These constrictions have prompted pharmaceutical companies to procure and utilize mass spectrometers in their quality control (QC) departments.

Get Free 10% Customization on Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=437

The mass spectrometry market comprises a network of players involved in the research and product development; instrument manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the mass spectrometry market are Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), SCIEX (a subsidiary of Danaher) (US), Bruker (US), PerkinElmer (US), JEOL (Japan), Analytik Jena (Germany), Hiden Analytical (UK), Rigaku (Japan), LECO (US), and DANI Instruments (Italy).

Avail Discount on Report:
https://www.marketsandmarkets.com/discountreports.asp?id=437